Skip to main content
. 2021 Feb 1;131(3):e140315. doi: 10.1172/JCI140315

Figure 2. Decreased VLA4 activation in M2 macrophages cocultured with ECs.

Figure 2

(A) KEGG pathway analysis of DEGs when comparing M2 versus M1 macrophages from cocultures. (B) Gene expression heatmap of differentially expressed integrin genes from A. (C) Expression of VLA4 in THP-1 macrophages detected by Western blot in different cocultures (n = 3). (D) Localization of VLA4 protein (green) in THP-1 macrophages by immunofluorescence analysis. CD68 (red) stains macrophages. DAPI stains cell nucleus. Scale bar: 20 μm. (E) Representative graph of flow cytometric analysis of active VLA4 levels in different subtypes of THP-1 macrophages from cocultures. (F) p–VE-cad expression in HUVECs cultured with macrophages that were transiently transfected with VLA4-specific shRNAs (shVLA4-a, shVLA4-b) or a control shRNA (shCtrl) (n = 3). (G) p–VE-cad expression in HUVECs from M1 macrophage–coculture system treated with CDP323 (n = 3). (H) p–VE-cad expression in HUVECs cocultured with macrophages that were transiently transfected with a VLA4-specific vector (Ove-VLA4) or a control vector (n = 3). (I) p–VE-cad expression in HUVECs from M2 macrophage–coculture system treated with THI0019 (n = 3). (J) Immunofluorescence analysis of p–VE-cad expression in HUVECs cultured with macrophages that were transiently transfected with a VLA4-specific vector (Ove-VLA4) or a control vector. Scale bar: 20 μm. (K) TRITC-dextran tracer fluorescence from coculture systems in which macrophages transiently transfected with a VLA4-specific vector (Ove-VLA4) or pretreated with THI0019, PS/2, and CDP323 are compared with the respective control (n = 5). Data represent 3 independent experiments. Results are shown as mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, Student’s t test (GI and K) and 1-way ANOVA (C and F).